1. Mutations in POGLUT1 in Galli–Galli/Dowling–Degos disease. (1st January 2017) Authors: Wilson, N.J.; Cole, C.; Kroboth, K.; Hunter, W.N.; Mann, J.A.; McLean, W.H.I.; Kernland Lang, K.; Beltraminelli, H.; Sabroe, R.A.; Tiffin, N.; Sobey, G.J.; Borradori, L.; Simpson, E.; Smith, F.J.D. Journal: British journal of dermatology Issue: Volume 176:Number 1(2017) Page Start: 270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mutations in POGLUT1 in Galli–Galli/Dowling–Degos disease. (24th September 2016) Authors: Wilson, N.J.; Cole, C.; Kroboth, K.; Hunter, W.N.; Mann, J.A.; McLean, W.H.I.; Kernland Lang, K.; Beltraminelli, H.; Sabroe, R.A.; Tiffin, N.; Sobey, G.J.; Borradori, L.; Simpson, E.; Smith, F.J.D. Journal: British journal of dermatology Issue: Volume 176:Number 1(2017) Page Start: 270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Therapeutic potential of novel PLK1 inhibitor CYC140 in esophageal cancer and acute leukemia. (December 2016) Authors: Moureau, S.; Pohler, E.; Kroboth, K.; Saladino, C.; MacKay, C.; Hollick, J.; Zheleva, D.; Frame, S.; Blake, D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗